MEDP - CIK 0001668397
The table below shows Medpace Holdings, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $151.79M | $125.84M | $152.68M | $80.08M | $46.26M | $57.32M |
| Capital expenditure | $6.81M | $9.99M | $5.50M | $9.51M | $9.26M | $6.51M |
| Investing cash flow | -$6.75M | -$9.99M | $2.53M | -$9.50M | -$11.21M | -$9.65M |
| Dividends paid | - | - | - | - | - |
Medpace Holdings, Inc. reported operating cash flow of $713.22M for fiscal year 2025. That is up 17.1% from $608.82M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $91.73M (FY 2016) to $713.22M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | $371.90M | $0.00 | $120.15M | $425.95M | $0.00 |
| Financing cash flow | $12.67M | -$345.97M | $7.66M | -$52.68M | -$412.08M | $9.10M |